"Expectations for Overseas Sales Expansion with Complementary Products"

Medical AI company Lunit announced on the 29th that it signed a Memorandum of Understanding (MOU) for overseas business cooperation in the medical AI field with Coreline Soft at the Radiological Society of North America (RSNA 2023) held in Chicago, USA, on the 8th (local time).


Seo Beom-seok (fifth from the left), CEO of Lunit, and Kim Jin-guk (fourth from the left), CEO of Coreline Soft, along with other officials, signed a business agreement for "overseas business joint cooperation" at the Lunit booth during the Radiological Society of North America (RSNA 2023) event held in Chicago, USA, on the 28th (local time), and are taking a commemorative photo. Photo by Lunit

Seo Beom-seok (fifth from the left), CEO of Lunit, and Kim Jin-guk (fourth from the left), CEO of Coreline Soft, along with other officials, signed a business agreement for "overseas business joint cooperation" at the Lunit booth during the Radiological Society of North America (RSNA 2023) event held in Chicago, USA, on the 28th (local time), and are taking a commemorative photo. Photo by Lunit

View original image

The signing ceremony was attended by about 10 officials, including Lunit CEO Bumseok Seo and Chief Medical Officer Kihwan Kim, Coreline Soft CEOs Jinkook Kim and Jungpil Choi, and Executive Director Sanghyun Baek.


Through this MOU, both companies agreed to mutually cooperate in the European, Middle East, and Africa (EMEA) markets in the future. Specifically, they agreed to collaborate on ▲establishing a partnership ▲support activities for each other's products and technologies ▲exploring joint entry strategies for overseas sales.


Additionally, both companies plan to pursue licensing agreements for AI solutions respectively and cooperate in joint sales and marketing activities in Europe and the EMEA region.


Lunit CEO Bumseok Seo said, "Since Coreline Soft possesses various three-dimensional solutions related to chest diseases, we expect technical and complementary synergy effects with Lunit's AI solutions," adding, "We will join forces to pioneer the European and EMEA markets through this business agreement."



Coreline Soft CEO Jinkook Kim stated, "The global medical AI market is growing rapidly, making cooperation between AI companies more important than ever," and added, "We are pleased to collaborate with Lunit, and by combining the core competencies and accumulated know-how of both companies, we will create high market share and business opportunities in the Middle East, Europe, and Africa regions."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing